HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Judith R Stabel Selected Research

Paratuberculosis (Johne's Disease)

3/2022Immunological Evaluation of Goats Immunized with a Commercial Vaccine against Johne's Disease.
1/2021Electrochemical Detection of Serum Antibodies Against Mycobacterium avium Subspecies paratuberculosis.
7/2020Comparison of Sheep, Goats, and Calves as Infection Models for Mycobacterium avium subsp. paratuberculosis.
10/2019Characterization of Ethanol Extracted Cell Wall Components of Mycobacterium avium Subsp. paratuberculosis.
12/2018Membrane and Cytoplasmic Proteins of Mycobacterium avium subspecies paratuberculosis that Bind to Novel Monoclonal Antibodies.
8/2017Cell wall peptidolipids of Mycobacterium avium: from genetic prediction to exact structure of a nonribosomal peptide.
7/2017Identification of Novel Seroreactive Antigens in Johne's Disease Cattle by Using the Mycobacterium tuberculosis Protein Array.
1/2016Composition and Potency Characterization of Mycobacterium avium subsp. paratuberculosis Purified Protein Derivatives.
9/2015ZAP-70, CTLA-4 and proximal T cell receptor signaling in cows infected with Mycobacterium avium subsp. paratuberculosis.
1/2015Mycobacterium avium Subspecies paratuberculosis Recombinant Proteins Modulate Antimycobacterial Functions of Bovine Macrophages.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Judith R Stabel Research Topics

Disease

34Paratuberculosis (Johne's Disease)
03/2022 - 09/2001
12Infections
03/2022 - 08/2003
2Disease Progression
01/2022 - 01/2014
1Inflammation (Inflammations)
08/2018
1Tuberculosis (Tuberculoses)
07/2017
1Erythema
01/2016

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
10/2019 - 08/2003
9AntigensIBA
01/2021 - 09/2001
4VaccinesIBA
03/2022 - 02/2007
4AntibodiesIBA
01/2021 - 08/2003
4Recombinant ProteinsIBA
07/2017 - 07/2012
4Membrane Proteins (Integral Membrane Proteins)IBA
07/2012 - 08/2003
3ProteomeIBA
07/2017 - 02/2007
3Indicators and Reagents (Reagents)IBA
01/2016 - 02/2007
3Lipoproteins (Lipoprotein)IBA
01/2015 - 01/2005
3Matrix Metalloproteinases (MMPs)IBA
03/2007 - 08/2003
2Interferon-gamma (Interferon, gamma)IBA
01/2016 - 03/2006
2DNA (Deoxyribonucleic Acid)IBA
11/2011 - 03/2010
1Cholecalciferol (Vitamin D3)FDA Link
01/2022
1CytokinesIBA
01/2022
1Horseradish PeroxidaseIBA
01/2021
1Monoclonal AntibodiesIBA
12/2018
1AcidsIBA
08/2018
1LipidsIBA
08/2017
1Tuberculin (PPD)IBA
01/2016
1Concanavalin AIBA
09/2015
1cysteine desulfuraseIBA
02/2015
1GelsIBA
02/2015
1Interleukin-10 (Interleukin 10)IBA
01/2015
1Mitogen-Activated Protein KinasesIBA
01/2015
1p38 Mitogen-Activated Protein KinasesIBA
01/2015
1Inactivated VaccinesIBA
01/2014
1FetuinsIBA
01/2009
1Glycoproteins (Glycoprotein)IBA
01/2009
1Orosomucoid (Seromucoid)IBA
01/2009
1Peptides (Polypeptides)IBA
01/2009
1Vitamin D-Binding ProteinIBA
01/2009
1Biomarkers (Surrogate Marker)IBA
01/2009
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2009
1Heat-Shock Proteins (Heat-Shock Protein)IBA
02/2008
1Cell ExtractsIBA
05/2007
1AminesIBA
02/2007
1feralIBA
07/2005
1RNA (Ribonucleic Acid)IBA
05/2005
1Interleukin-5 (Interleukin 5)IBA
05/2005
1Messenger RNA (mRNA)IBA
05/2005
1Immunologic Factors (Immunomodulators)IBA
01/2005
1Oxygen (Dioxygen)IBA
08/2003
1VancomycinFDA LinkGeneric
05/2002

Therapy/Procedure

1Therapeutics
07/2020
1Intradermal Injections
01/2007